JP2014530842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530842A5 JP2014530842A5 JP2014536290A JP2014536290A JP2014530842A5 JP 2014530842 A5 JP2014530842 A5 JP 2014530842A5 JP 2014536290 A JP2014536290 A JP 2014536290A JP 2014536290 A JP2014536290 A JP 2014536290A JP 2014530842 A5 JP2014530842 A5 JP 2014530842A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- group
- transthyretin
- pharmaceutically acceptable
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11382326 | 2011-10-24 | ||
| EP11382326.4 | 2011-10-24 | ||
| PCT/EP2012/070945 WO2013060668A1 (en) | 2011-10-24 | 2012-10-23 | New therapy for transthyretin-associated amyloidosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530842A JP2014530842A (ja) | 2014-11-20 |
| JP2014530842A5 true JP2014530842A5 (enExample) | 2015-12-10 |
| JP6068484B2 JP6068484B2 (ja) | 2017-01-25 |
Family
ID=47076222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014536290A Active JP6068484B2 (ja) | 2011-10-24 | 2012-10-23 | トランスサイレチン関連アミロイドーシスの新規療法 |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US9610270B2 (enExample) |
| EP (1) | EP2770988B1 (enExample) |
| JP (1) | JP6068484B2 (enExample) |
| KR (1) | KR102017354B1 (enExample) |
| CN (1) | CN103889407B (enExample) |
| AU (2) | AU2012327275B2 (enExample) |
| BR (1) | BR112014009322B1 (enExample) |
| CA (1) | CA2852808C (enExample) |
| CL (1) | CL2014000893A1 (enExample) |
| CY (1) | CY1118151T1 (enExample) |
| ES (1) | ES2593038T3 (enExample) |
| IL (1) | IL231907B (enExample) |
| MX (2) | MX347784B (enExample) |
| PL (1) | PL2770988T3 (enExample) |
| PT (1) | PT2770988T (enExample) |
| RU (2) | RU2747536C2 (enExample) |
| SG (2) | SG11201401215VA (enExample) |
| WO (1) | WO2013060668A1 (enExample) |
| ZA (1) | ZA201402546B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2770988T3 (pl) * | 2011-10-24 | 2017-01-31 | Som Innovation Biotech S.L. | Nowa terapia amyloidozy związanej z transtyretyną |
| WO2016033326A2 (en) * | 2014-08-29 | 2016-03-03 | Alnylam Pharmaceuticals, Inc. | Methods of treating transthyretin (ttr) mediated amyloidosis |
| EP3275433A1 (en) * | 2016-07-29 | 2018-01-31 | Som Innovation Biotech S.L. | Sustained release composition comprising micronized tolcapone |
| BR112020018715A2 (pt) * | 2018-03-12 | 2021-01-05 | Corino Therapeutics, Inc. | Terapia de combinação para amiloidose associada a ttr |
| WO2020243720A1 (en) * | 2019-05-31 | 2020-12-03 | Plex Pharmaceuticals, Inc. | Pharmacological agents for treating protein aggregation diseases of the eye |
| CN114324693B (zh) * | 2022-01-14 | 2023-01-13 | 大连博源医学科技有限公司 | 一种血液中转甲状腺素蛋白(ttr)四聚体浓度测定的预处理方法和检测方法 |
| WO2024081554A2 (en) * | 2022-10-10 | 2024-04-18 | Corino Therapeutics, Inc. | Modified release tolcapone formulations |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744368A (en) | 1993-11-04 | 1998-04-28 | Research Foundation Of State University Of New York | Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR) |
| WO1998027972A2 (en) | 1996-12-23 | 1998-07-02 | Texas A & M University | Anti-amyloidogenic agents |
| FI20002044A0 (fi) * | 2000-09-15 | 2000-09-15 | Orion Yhtymae Oyj | Comt-entsyymiä estäviä naftaleenijohdannaisia |
| CA2440293C (en) | 2001-03-15 | 2012-01-24 | Proteotech, Inc. | Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders |
| CA2473102A1 (en) | 2002-01-29 | 2003-07-29 | Protemix Corporation Limited | Suppression of cytotoxic protein conformers |
| US20040175382A1 (en) | 2003-03-06 | 2004-09-09 | Schafer Peter H. | Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system |
| CN1921856A (zh) * | 2004-02-20 | 2007-02-28 | 诺瓦提斯公司 | 用于治疗神经变性疾病和认知障碍的dpp－iv抑制剂 |
| JP2007523122A (ja) | 2004-02-20 | 2007-08-16 | ノバルティス アクチエンゲゼルシャフト | 神経変性障害および認知障害の処置のためのｄｐｐ−ｉｖ阻害剤 |
| WO2005118511A2 (en) * | 2004-05-20 | 2005-12-15 | The Scripps Research Institute | Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| CA2577268A1 (en) | 2004-08-30 | 2006-03-09 | Seo Hong Yoo | Neuroprotective effect of solubilized udca in focal ischemic model |
| GB2429645A (en) | 2006-03-10 | 2007-03-07 | Sekhsaria Chemicals Ltd | Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent |
| US20120016037A1 (en) | 2006-07-24 | 2012-01-19 | Frank Toppo | Method for prevention and treatment of Alzheimers |
| GB0718718D0 (en) | 2007-09-25 | 2007-11-07 | Pentraxin Therapeutics Ltd | Compound and use thereof |
| DE102010010572A1 (de) | 2010-03-08 | 2011-09-08 | Mahle International Gmbh | Trockenseparator |
| PL2770988T3 (pl) * | 2011-10-24 | 2017-01-31 | Som Innovation Biotech S.L. | Nowa terapia amyloidozy związanej z transtyretyną |
-
2012
- 2012-10-23 PL PL12778323T patent/PL2770988T3/pl unknown
- 2012-10-23 US US14/353,459 patent/US9610270B2/en active Active
- 2012-10-23 MX MX2014004863A patent/MX347784B/es active IP Right Grant
- 2012-10-23 JP JP2014536290A patent/JP6068484B2/ja active Active
- 2012-10-23 BR BR112014009322-9A patent/BR112014009322B1/pt active IP Right Grant
- 2012-10-23 ES ES12778323.1T patent/ES2593038T3/es active Active
- 2012-10-23 CN CN201280051812.8A patent/CN103889407B/zh not_active Expired - Fee Related
- 2012-10-23 SG SG11201401215VA patent/SG11201401215VA/en unknown
- 2012-10-23 MX MX2017006182A patent/MX385516B/es unknown
- 2012-10-23 EP EP12778323.1A patent/EP2770988B1/en active Active
- 2012-10-23 WO PCT/EP2012/070945 patent/WO2013060668A1/en not_active Ceased
- 2012-10-23 CA CA2852808A patent/CA2852808C/en active Active
- 2012-10-23 RU RU2017119539A patent/RU2747536C2/ru active
- 2012-10-23 KR KR1020147010767A patent/KR102017354B1/ko active Active
- 2012-10-23 PT PT127783231T patent/PT2770988T/pt unknown
- 2012-10-23 AU AU2012327275A patent/AU2012327275B2/en not_active Ceased
- 2012-10-23 RU RU2014114930A patent/RU2623062C2/ru active
- 2012-10-23 SG SG10201609933WA patent/SG10201609933WA/en unknown
-
2014
- 2014-04-03 IL IL231907A patent/IL231907B/en active IP Right Grant
- 2014-04-08 ZA ZA2014/02546A patent/ZA201402546B/en unknown
- 2014-04-09 CL CL2014000893A patent/CL2014000893A1/es unknown
-
2016
- 2016-09-20 CY CY20161100934T patent/CY1118151T1/el unknown
-
2017
- 2017-03-02 US US15/448,054 patent/US10045956B2/en active Active
- 2017-04-21 AU AU2017202670A patent/AU2017202670B2/en not_active Ceased
-
2018
- 2018-08-13 US US16/101,882 patent/US10449169B2/en active Active
-
2019
- 2019-09-12 US US16/569,055 patent/US10786473B2/en active Active
-
2020
- 2020-08-28 US US17/005,893 patent/US11564899B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530842A5 (enExample) | ||
| RU2018133158A (ru) | Способы применения агонистов fxr | |
| JP2019517587A5 (enExample) | ||
| JP2018534348A5 (enExample) | ||
| JP2009514874A5 (enExample) | ||
| JP2009530398A5 (enExample) | ||
| JP2019521988A5 (enExample) | ||
| JP2016510317A5 (enExample) | ||
| JP2014511892A5 (enExample) | ||
| AR048431A1 (es) | Formulaciones galenicas de compuestos organicos | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| JP2013542261A5 (enExample) | ||
| JP2008543854A5 (enExample) | ||
| JP2006504795A5 (enExample) | ||
| JP2013531031A5 (enExample) | ||
| HRP20170358T1 (hr) | Inhibitori histonskih demetilaza | |
| JP2016534063A5 (enExample) | ||
| AR094374A1 (es) | Composiciones y métodos para el tratamiento de trastornos metabólicos | |
| JP2011505347A5 (enExample) | ||
| ATE556061T1 (de) | Therapeutisches oder prophylaktisches mittel gegen multiple sklerose | |
| RU2014114930A (ru) | Новая терапия транстиретин-ассоциированного амилоидоза | |
| JP2017508817A5 (enExample) | ||
| JP2012502047A5 (enExample) | ||
| JP2011088926A5 (enExample) | ||
| JP2009517411A5 (enExample) |